USDA researchers used edible blue-green algae to protect honey bees against viruses
On Mar. 19, 2024, scientists at the United States Department of Agriculture (USDA)ï¾’s Agricultural Research Service (ARS) announced…
Moderna to make milestone payments to NIH for COVID vaccine
On Feb. 24, 2023, Moderna announced will make certain contingent development, commercial and regulatory milestone payments to the…
U.S. patent appeal board ruled against University of California in CRISPR interference
On Mar. 1, 2022, the Patent and Trial Appeal Board of the U.S .Patent and Trademark Office issued…
Leading Generic Drug Makers Unite to Pledge Capacity for Developing and Delivering Affordable COVID-19 Interventions as Pandemic Intensifies
On Sept. 21, 2021, the Medicines Patent Pool (MPP) announced that it had signed a licence agreement with…
Athenex and Center for Cell and Gene Therapy announced allowance of first U.S. patent around CAR-NKT cell therapy
On Oct. 18, 2021, Athenex and the Center for Cell and Gene Therapy at Baylor College of Medicine,…
The Medicines Patent Pool secured its first licence for malaria, tuberculosis and hepatitis C
On Sept. 21, 2021, the Medicines Patent Pool (MPP) announced that it had signed a licence agreement with…
Novavax initiated phase 1/2 clinical trial of combination vaccine for COVID-19 and seasonal influenza
On Sept. 8, 2021, Novavax announced enrollment of the first participants in a Phase 1/2 study to evaluate…
Celsion filed provisional U.S. patent application for broad range of next generation DNA vaccines
On Jan. 28, 2021, Celsion announced the filing of a provisional U.S. patent application for a novel DNA-based,…
AXIM Biotechnologies completed successful Covid-19 live virus test and filed amended EUA
On Dec. 15, 2020, AXIM Biotechnologies announced the development and patent filing for an enzyme-linked immunosorbent assay (ELISA)-based…
AXIM Biotechnologies filed patent for virus binding recombinant protein for SARS-CoV-2 and began manufacturing
On Dec. 3, 2020, AXIM Biotechnologies announced the development and patent filing for an enzyme-linked immunosorbent assay (ELISA)-based…
Viatris announced FDA tentative approval of pediatric formulation of Dolutegravir under PEPFAR
On Nov. 23, 2020, Viatris announced tentative approval from the FDA for a New Drug Application for pediatric…
AXIM Biotechnologies filed patent for world’s first face mask designed to capture SARS-CoV-2 COVID-19
On Sept. 29, 2020, AXIM Biotechnologies announced that it had filed a provisional patent for a first-in-class face…
AXIM Biotechnologies applied for FDA Emergency Use Approval for high throughput, neutralizing antibody diagnostic test for COVID-19
On Aug. 5, 2020, AXIM Biotechnologies announced the development, patent filing and Emergency Use Approval (EUA) filing of…
Adamis Pharma announced license to commercialize Tempol, a novel investigational anti-inflammatory and antioxidant drug for treatment of respiratory diseases
On Jun. 15, 2020, Adamis Pharma announced a license to commercialize Tempol, a novel patented investigational drug for…
AIM ImmunoTech filed provisional patent application for ose of Ampligen(R) as potential therapy for COVID-19 Induced chronic fatigue
On Jun. 11, 2020, AIM ImmunoTech announced that it had filed a provisional patent application for, among other…
iBio announced second COVID-19 vaccine program
On Jun. 4, 2020, iBio announced it had initiatied preclinical immunization studies for its second COVID-19 vaccine platform….
Catalent signed development agreement with Ennaid Therapeutics on its COVID-19 lead program
On May 13, 2020,Catalent announced a collaboration with Ennaid Therapeutics to develop an oral, antiviral treatment targeted at…
USPTO announced COVID-19 Prioritized Examination Pilot Program for small and micro entities
On May 8, 2020, the U.S. Patent and Trademark Office (USPTO) announced a new COVID-19 Prioritized Examination Pilot…
Medigen Vaccine Biologics signed a license agreement with NIH on COVID-19 vaccine
On May 5, 2020, Medigen Vaccine Biologics (MVB) announced a global commercial license agreement with National Institutes of…
Biotechnology | COVID-19 | Diagnostics | Life Science News | Medical Device | Non-Profit Research | Pharmaceutical | Therapeutics
USPTO launched platform to facilitate connections between patent holders and potential licensees in key technologies
On May 4, 2020, the U.S. Patent and Trademark Office (USPTO) unveiled a new web-based intellectual property marketplace…
Cocrystal Pharma expanded exclusive license agreement with Kansas State University Research Foundation to new Coronavirus antiviral compound
On Apr. 22, 2020, Cocrystal Pharma announced it has expanded its previously announced license agreement with Kansas State…
New virus detection process under development at Rutgers-Camden
On Apr. 21, 2020,the fight against the coronavirus is underway in a Rutgers Universityï¾–Camden research laboratory, where chemistry…
Mesa Biotech to ship 10,000 Accula SARS-CoV-2 tests for 30 minute rapid molecular point of care diagnosis
On Apr. 7, 2020, Mesa Biotech announced it was shipping 10,000 of its Accula SARS-CoV-2 molecular rapid point…
Pluristem and Charit’ University of Medicine Berlin joinly target potential treatment for respiratory and inflammatory Intratissue complications caused by COVID-19
On Mar. 12, 2020, Pluristem Therapeutics announced it a collaborative agreement with the BIH Center for Regenerative Therapy…
Heat Biologics launched program to develop vaccine to protect against COVID-19 coronavirus
On Mar. 3, 2020, Heat Biologics announced the Company has formally launched a program within its wholly-owned subsidiary,…
Chembio Diagnostics and Takeda Pharmaceutical announced collaboration to develop point-of-care diagnostic test
On Jul. 18, 2019, Chembio Diagnostics announced a collaboration with Shire Human Genetic Therapies, a wholly owned subsidiary…
Chembio Diagnostics announced agreement with Perseus Science to advance point-of-care concussion test
On May 7, 2019, Chembio Diagnostics announced an agreement with Perseus Science Group, to advance the development of…
Pascal Biosciences commenced cannabinoid testing of human volunteers and patients
On Jan. 24, 2019, Pascal Biosciences announced the testing of cannabinoids in human subjects for its immune stimulatory…
Biotechnology | Life Science News | Medical Device | Medicine | Non-Profit Research | Orthopedic | Therapeutics
Gary K Michelson donated $50 million to USC to fund the Michelson Center for Convergent Bioscience
On Jan. 13, 2014, Gary K. Michelson, a retired orthopaedic spinal surgeon whose groundbreaking work generated more than…
Syntrix Biosystems won $115 million judgment in patent case against Illumina, the largest patent verdict in Washington state history
On Jun. 20, 2013 – Syntrix Biosystems announced a federal court in Tacoma, had granted the Auburn-based company…